Clinical Trial Update: Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating Infigratinib before surgery for upper tract urothelial carcinoma has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma

Drugs mentioned

• Infigratinib (infigratinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Renal Pelvis and Ureter Urothelial Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-01-01